Therefore, compared with liraglutide, CFP exerted a similar glycemic control effect and a stronger lipid-lowering effect in the diabetic mice, suggesting that CFP might be one potent alternative of dietary intervention for the treatment of T2D. The gene discussed is CFP; the disease is type 2 diabetes mellitus.